HIs | All patients | Group 1 | Group 2 | ||
---|---|---|---|---|---|
N = 10 | N = 24 | N = 9 | N = 15 | ||
FMA-UE | Median (min; max) | 66 (66; 66) | 64 (28; 66) | 66 (66; 66) | 59 (28; 65) |
Female | N (%) | 6 (60) | 11 (46) | 5 (55) | 6 (42) |
Age | mean (SD) | 64 (11) | 61 (11) | 66 (9) | 57 (12) |
Time since stroke | 6–12 months | 1 (4) | 0 (0) | 1 (7) | |
12–36 months | 9 (38) | 3 (33) | 6 (42) | ||
> 36 months | 14 (58) | 6 (66) | 8 (56) | ||
Localisation | Cortical | 13 (54) | 5 (55) | 8 (56) | |
Subcortical | 10 (42) | 4 (44) | 6 (42) | ||
MoCA | Median (min; max) | (25; 30) * | 27 (8; 30) | 27 (23; 30) | 27 (8; 29) |
ABILHAND | Median (min; max) | 2.8 (− 0.9; 6.0) | 4.4 (1.2; 6) | 1.3 (− 0.9; 4) | |
SIS | Median (min; max) | 74 (42; 99) | 89 (57; 99) | 68 (42; 93) |